Varying prevalence of embB codon 306 mutations in ethambutol-resistant clinical Mycobacterium tuberculosis isolates from Beirut and Dubai

Journal of Chemotherapy

Volumn 20, Issue 2, 2008, Pages 285-287

  Ahmad, Suhail ^a   Itani, L Y ^b   Fares, E ^c   Araj, G F ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c RASHID HOSPITAL   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM ISOLATE; CODON; DRUG SENSITIVITY; DUBAI; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LEBANON; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUBERCULOSIS;

EID: 44849090699     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.2.285     Document Type: Article

References (12)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367: 938-940.
2. Aziz MA, Wright A, Laszlo A, et al. for the WHO/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Epidemiology of antituberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis. Lancet 2006; 368: 2142-2154.
3. Telenti A, Phillipp W, Sreevatsan S, et al. The emb operon, a unique gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997; 3: 567-570.
4. Sreevatsan S, Stockbauer KE, Pan X, et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997; 41: 1677-1681.
5. Ahmad S, Jaber A-A, Mokaddas E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis 2007; 87: 123-129.
6. Hazbon MH, Bobadilla del Valle M, Guerrero MI, et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 2005; 49: 3794-3802.
7. Mokrousov I, Ottem T, Vyshnevskiy B, Narvskaya O. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing. J Clin Microbiol 2002; 40: 3810-3813.
8. Pinke C, Rusch-Gerdes S, Nieman S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2006; 50: 1900-1902.
9. Ahmad S, Mokaddas E. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. Int J Antimicrob Agents 2004; 23: 473-479.
10. Ahmad S, Mokaddas E, Jaber A-A. Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations. Mol Cell Probes 2004; 18: 299-306.
11. Araj GF, Saade M, Itani LY. Nationawide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon. Int J Tuberc Lung Dis 2006; 10: 63-67.
12. Dissanayake S, Usmani A, Sheikh FA, Sheek-Hussein M, Ameen AM, Lukic ML. Mycobacterium tuberculosis in the United Arab Emirates: evidence of local transmission with unique strains. Trans Royal Soc Trop Med Hyg 2001; 95: 591-594.